Medications

FDA chief says long-awaited opioid review still in the works

A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency's commissioner said Tuesday.

page 1 from 40